Clin2
NCT06404775Likely a fitNot yet recruiting

Oil vs. Tamoxifen for severe breast pain in premenopausal women

Mastalgia

Part of Pain clinical trials.

This trial compares a new oil applied to the breast (External Mastalgia-oil) with the standard pill tamoxifen for treating severe breast pain in women who still have periods. The goal is to see if the oil is as effective as tamoxifen but with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
456 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are premenopausal female, at least 18 years old, with regular periods.
  • You have had moderate to severe breast pain for at least 6 months, with pain lasting 7 days or more each cycle.
  • Your breast ultrasound or mammogram (if needed) shows no suspicious findings (BI-RADS 1, 2, or 3).
  • You have not taken any hormone medications, pain relievers, or tamoxifen in the past 3-6 months.
  • You have not had breast surgery, cancer, or blood clots in the last 5 years.
  • You are willing to use effective birth control, not pregnant, and not breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06966245Recruiting· Phase 3
Oil for severe breast pain in premenopausal women

This trial tests whether an oil applied to the breast can reduce severe breast pain in premenopausal women. If you have had breast pain for at least six months and it is not caused by the chest wall, this study may be a good fit.

Guangzhou
NCT06760988Not yet recruiting
Testing a supplement for menstrual pain relief

This study tests a supplement called CL22205 to see if it can reduce menstrual pain and improve quality of life for women with longer cycles and monthly discomfort. If you have period pain that bothers you and your cycle is between 36 and 45 days, this may be an option to explore.

NCT07100782Recruiting· Phase 3
Estrogen & pain trial for endometriosis pelvic pain

This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.

Ann Arbor, Michigan
NCT06787118Not yet recruiting· Phase 3
CBD for joint pain from hormone therapy in early breast cancer

This trial tests whether a CBD oral solution can help relieve joint pain caused by hormone therapy (aromatase inhibitors) in people with early breast cancer. It aims to improve your quality of life during treatment.

Villejuif
NCT07318688Recruiting· Phase 3
Testing HMI-115 for endometriosis pain

This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.

Beijing, Beijing Municipality
NCT06154590Not yet recruiting
Anastrozole vs. tamoxifen for early breast cancer

This trial compares two hormone therapies, anastrozole and tamoxifen, for treating early breast cancer. It aims to see which one works better to prevent the cancer from coming back.

Colorado Springs, Colorado

Hear when a new Mastalgia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.